Driving Commercial Strategy in ALL: The Critical Role of Lab Data
For pharmaceutical commercial teams, understanding the full patient journey is critical. In the...
7 Best Practices for Lab Data Licensing: Maximize Value in Oncology & Genomics
By Jason Bhan, MD, Bill Paquin, Chris Hayes, Sundeep Bhan, Michael Cheyne [Bonus: Link to the free...
Shining a Light on Colorectal Cancer Awareness Month
Shining a Light on Colorectal Cancer Awareness Month March is Colorectal Cancer Awareness Month, a...
Keeping the Focus on Kidney Health: Beyond World Kidney Day and the Nuances of CKD
World Kidney Day, observed yesterday on March 13, served as a powerful reminder of the critical...
Beyond Claims: The True Value of Lab Data in Prostate Cancer Therapy Commercialization
Prostate cancer (PC) remains a significant men's health concern, demanding innovative treatment...
Optimizing CLL Commercial Strategies with Lab Insights
Chronic Lymphocytic Leukemia (CLL) presents a complex treatment landscape. While advancements have...
Supporting HAE Commercial Teams with Prognos Health Lab Data
Hereditary angioedema (HAE) is a rare and debilitating condition affecting an estimated 1 in 50,000...
Illuminating Acromegaly: Lab Data Can Change HCP Engagement
Acromegaly, a rare hormonal disorder caused by excess growth hormone (GH) production, often goes...
Rapidly Identifying HCPs Treating AML: The Lab Data Advantage
Acute myeloid leukemia (AML) is a rapidly progressing cancer of the blood and bone marrow,...
Unlocking Precision Targeting in Lysosomal Storage Disorders: How Prognos Health Empowers Commercial Teams
Lysosomal Storage Disorders (LSDs) present a unique challenge for pharmaceutical and biotech...